Home health frontier Checkable is positioned at the intersection of at‑home diagnostics and telemedicine, offering a FDA‑approved at‑home strep test paired with a proprietary digital platform. This presents a scalable entry point for expanding home health testing services and remote care offerings to healthcare providers and payors.

Product expansion Recent launch of women’s and maternal at‑home diagnostics (UTI test, vaginal pH, breast milk strips) signals a broader portfolio that can be upsold to existing customers and used to cross‑sell companion telemedicine services, creating recurring consumer engagement opportunities.

Telemedicine leverage Integrated telemedicine capability allows fast triage and treatment without office visits, which can be monetized through subscription models, direct-to-consumer plans, or employer health benefits partnerships to reduce clinical costs and improve access.

Growth potential Revenue is currently in the sub‑$1M range with a small team, indicating a low‑cost base for rapid go‑to‑market scaling through partnerships with clinics, clinics’ networks, and health plans, leveraging existing tech stack for rapid deployment.

Strategic partnerships Given competitors with larger footprints and the emerging at‑home diagnostics trend, Checkable can pursue collaborations with major laboratories, pharmacies, and digital health platforms to expand distribution, validation, and reimbursement opportunities, accelerating market penetration.